Share Facebook Twitter LinkedIn Pinterest Email Merck Keytruda with Eisai’s Lenvima succeeds in late-stage trial for liver cancer Source: Seekingalpha cancer Eisais Keytruda latestage Lenvima liver Merck succeeds trial